Antigen-Specific TCR-T Cells for Acute Myeloid Leukemia: State of the Art and Challenges.

Kang, Synat; Li, Yisheng; Qiao, Jingqiao; Meng, Xiangyu; He, Ziqian; Gao, Xuefeng; Yu, Li

Kang, Synat; Li, Yisheng; Qiao, Jingqiao; Meng, Xiangyu; He, Ziqian; Gao, Xuefeng; Yu, Li.

Afiliación

Kang S; Department of Hematology and Oncology, International Cancer Center, Shenzhen Key Laboratory of Precision Medicine for Hematological Malignancies, Shenzhen University General Hospital, Shenzhen University Clinical Medical Academy, Shenzhen University Health Science Center, Shenzhen, China.
Li Y; Central Laboratory, Shenzhen University General Hospital, Shenzhen, China.
Qiao J; Central Laboratory, Shenzhen University General Hospital, Shenzhen, China.
Meng X; Central Laboratory, Shenzhen University General Hospital, Shenzhen, China.
He Z; Central Laboratory, Shenzhen University General Hospital, Shenzhen, China.
Gao X; Department of Hematology and Oncology, International Cancer Center, Shenzhen Key Laboratory of Precision Medicine for Hematological Malignancies, Shenzhen University General Hospital, Shenzhen University Clinical Medical Academy, Shenzhen University Health Science Center, Shenzhen, China.
Yu L; Central Laboratory, Shenzhen University General Hospital, Shenzhen, China.

Front Oncol ; 12: 787108, 2022.

Article en En | MEDLINE | ID: mdl-35356211

Palabras clave

TCR-T cells; acute myeloid leukemia; allo-HSCT; immune escape; immunotherapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google